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Abstract: The formation of a protein layer “corona” on the nanoparticle surface upon entry into
a biological environment was shown to strongly influence the interactions with cells, especially
affecting the uptake of nanomedicines. In this work, we present the impact of the protein corona on
the uptake of PEGylated zein micelles by cancer cells, macrophages, and dendritic cells. Zein was
successfully conjugated with poly(ethylene glycol) (PEG) of varying chain lengths (5K and 10K) and
assembled into micelles. Our results demonstrate that PEGylation conferred stealth effects to the
zein micelles. The presence of human plasma did not impact the uptake levels of the micelles by
melanoma cancer cells, regardless of the PEG chain length used. In contrast, it decreased the uptake
by macrophages and dendritic cells. These results therefore make PEGylated zein micelles promising
as potential drug delivery systems for cancer therapy.
Keywords: zein micelles; poly(ethylene glycol); protein corona; cellular uptake; cancer cells;
macrophages; dendritic cells
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1. Introduction
Zein, a prolamin protein extracted from corn, has been widely used in food, pharmaceutical, and biomedical applications because of its generally regarded as safe (GRAS)
status [1–3]. It is classified into four main types, depending on their molecular weight
(MW), charge, and solubility [4]. Its major fraction, α-zein, consists of 75–80% of the total
zein with a MW of 19–24 kDa, while β-zein is a polymer of 17–18 kDa. γ-zein contains
two parts of 27 kDa and 18 kDa, and δ-zein is a minor fraction of 10 kDa [5–8]. Zein
exhibits an amphiphilic molecular structure. It contains more than 50% lipophilic amino
acids, leading to insolubility in water. Its high glutamine content also makes it insoluble in
absolute alcohol [9], but facilitates conjugation with biomolecules via its N-terminal group.
Due to its good biocompatibility and biodegradability, zein has shown high potential in
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carrier systems for the delivery of nutraceutical and drugs [10–15] and for use in cancer
research [16,17].
However, because of their hydrophobicity and protein nature, zein particles may
cause immunogenicity, which could limit their use for drug delivery [18]. To overcome this
issue, the modification of zein by conjugation with poly(ethylene glycol) (PEG) has been
proposed to create a steric shielding of the delivery system, thus reducing opsonization
and providing a sustained release of the carried drug. Podaralla et al. and Song et al.
previously demonstrated that PEGylation of white zein (containing a very low level of
xanthophylls (less than 0.001%)) could generate stable micelles that improved the solubility
and stability of the hydrophobic drug curcumin as well as enhancing its uptake by cancer
cells [19,20]. So far, there have been no reports of PEGylation to yellow zein (a mixture of α,
β, γ, and δ-zein, containing 8–9% of xanthophyll pigments, including lutein, zeaxanthin,
and β-cryptoxanthin).
It is well known that physicochemical properties of delivery systems (e.g., size, shape,
charge, and surface chemistry) strongly influence their interactions with cells [21]. However,
when exposed to biological fluids, nanoparticles tend to interact with biomolecules, leading
to the formation of a complex layer of proteins called a protein corona. Protein corona can
be classified into “hard corona” and “soft corona” depending on binding affinity and the
time required for the exchange of adsorbed proteins. The hard corona corresponds to the
innermost layer of proteins that interact directly with the nanomaterial surface with high
affinity and require a high exchange time (about several hours). In contrast, the soft corona
is made of loosely bound proteins that adsorb with low affinity and can undergo a rapid
exchange of biomolecules within seconds or minutes [22,23]. The presence of the protein
corona significantly changes the surface properties of the nanocarrier, providing a new
biological identity which impacts its actual biological responses within the body, such as
cellular uptake, kinetics, and toxicity [23,24].
Although PEGylation is often used to prevent nonspecific protein adsorption on
delivery systems [25,26], little is known about the impact of the protein corona on PEGylated
zein micelles and their interactions with cells, or about the PEG chain length required to
obtain stealth zein micelles. The aims of this project were therefore (1) to synthesize
zein micelles conjugated with low and high MW methoxy PEG (mPEG) and entrap the
hydrophobic drug model Nile red, (2) to assess the impact of PEG MW on their uptake
efficiency in melanoma cancer cells, and (3) to investigate the effect of protein corona
surrounding these micelles upon contact with human plasma on their cellular uptake
in vitro on cancer cells, macrophages, and dendritic cells.
2. Materials and Methods
2.1. Cell Lines and Reagents
Yellow zein, Nile red, and all other chemicals that are not specifically mentioned
below were purchased from Sigma-Aldrich (Poole, UK). Methoxy PEG succinimidyl carboxymethyl ester with a MW of 5 kDa (mPEG-SCM-5000) and 10 kDa (mPEG-SCM-10K)
were obtained from JenKem Technology (Plano, TX, USA). Dulbecco’s Modified Eagle
Medium (DMEM) and Roswell Park Memorial Institute (RPMI) 1640 cell culture media,
L-glutamine, fetal bovine serum (FBS), penicillin-streptomycin, and TrypLE® Express came
from Life Technologies (Paisley, UK). 4–20% Mini-PROTEAN® TGXTM gels, Precision Plus
ProteinTM Dual Color Standards, 10× TGS buffer, 2× Laemmli sample buffer, and Silver
Stain PlusTM Kit were purchased from Bio-Rad (Watford, UK). Vectashield® mounting
medium containing 40 ,6-diamidino-2-phenylindole (DAPI) came from Vector Laboratories
(Peterborough, UK). Bioware® B16-F10-luc-G5 mouse melanoma cells were purchased from
Caliper Life Sciences (Hopkinton, MA, USA).
2.2. Synthesis and Characterization of PEGylated Zein
The synthesis of PEGylated zein was adapted from a method published by Podaralla
et al. [19]. Briefly, yellow zein (0.1 g) was dissolved in 4 mL of 90% (v/v) ethanol. Different
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amounts of mPEG-SCM (0.05 g of mPEG-SCM (5 kDa) for mPEG5K-zein; 0.1 g of mPEGSCM (10 kDa) for mPEG10K-zein) were dissolved in 1 mL of 90% (v/v) ethanol. PEG
and zein solutions were mixed under stirring (100 rpm, Fisherbrand® magnetic stirrer,
Thermo Fisher Scientific, Waltham, MA, USA) for 3 h at 25 ◦ C. One mL of glycine solution
(1 M) was added to stop the reaction, followed by the addition of 5 mL citrate buffer (pH
7.4) to precipitate the PEGylated zein. Free PEG and ethanol were removed by dialysis
(MW cut-off: 12–14 kDa) against distilled water (2.5 L) under continuous stirring (120 rpm)
at 25 ◦ C for 48 h. The distilled water was changed 3 times during the dialysis process.
The resulting product was then lyophilized using a Christ Epsilon 2–4 LSC® freeze dryer
(Osterode am Harz, Germany). The obtained mPEG5K-zein and mPEG10K-zein were
stored at −20 ◦ C. Their composition is summarized in Table 1.
Table 1. Composition of the two mPEG-zein synthesized in the study.
Composition

Weight Ratio

Molar Ratio

mPEG5K-zein

mPEG5K:zein

0.5:1

2.3:1

mPEG10K-zein

mPEG10K:zein

1:1

2.3:1

To confirm the PEGylation of zein, samples were directly analyzed by Attenuated
Total Reflection—Fourier Transform Infrared spectroscopy (ATR–FTIR). The ATR–FTIR
spectrum of each sample was taken with a Bruker Tensor II-FTIR® spectrophotometer
(Billerica, MA, USA), using 100 scans with 2 cm−1 resolution. Data were collected within a
range of 400–4000 cm−1 at 20 ◦ C.
2.3. Preparation of mPEG-Zein Micelles Encapsulating Nile Red
Nile red (0.25 mg) and mPEG-zein (50 mg) were dissolved in 10 mL of ethanol (90%,
v/v). To allow partitioning of the Nile red into mPEG-zein micelles, the mixture was
stirred (100 rpm) at 37 ◦ C overnight, before being dialyzed and lyophilized as described in
Section 2.2.
2.4. Characterization of mPEG-Zein Micelles
2.4.1. Characterization of Core-Shell Structure of mPEG-Zein Micelles
To characterize the core-shell structure of the micelles, mPEG-zein conjugates
(5 mg/mL in deuterium oxide (D2 O) and deuterated dimethyl sulfoxide (DMSO-d6 ))
were analyzed by Proton Nuclear Magnetic Resonance (1 H NMR). 1 H NMR spectra were
recorded at 500 MHz using a Bruker Avance® III HD500 NMR spectrometer (Billerica, MA,
USA), and the core-shell structure was confirmed by comparing the spectra in DMSO-d6
and D2 O.
2.4.2. Determination of Critical Micelle Concentration (CMC)
The CMC of mPEG-zein micelles was determined using Nile red as a hydrophobic
fluorescent probe. Briefly, 32 µL Nile red solution (1 mg/mL in methanol) was added to
plastic vials. After complete evaporation of methanol, 1 mL mPEG5K-zein and mPEG10Kzein (concentration range 0.001–1 mg/mL in 5% (w/v) glucose solution) was added to
the vials. Each sample was vortexed (using a Fisherbrand® vortex mixer, Thermo Fisher
Scientific, Waltham, MA, USA) and incubated overnight at 25 ◦ C before measurement.
Fluorescence intensity was measured with a Varian Cary Eclipse® spectrofluorometer (Palo
Alto, CA, USA). The excitation wavelength was fixed at 550 nm, and the emission spectra
were recorded from 570 nm to 800 nm (excitation and emission slit widths: 5 and 20 nm).
The ratio of Nile red emission intensity at the wavelength of maximum emission (λmax ) in
the presence of mPEG-zein (I) over the fluorescence in its absence (I0 , in 5% (w/v) glucose
solution) was plotted as a function of mPEG-zein concentration. The point at which the
tangents to the two linear portions of the graph intersect was defined as the CMC.
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2.4.3. Morphology of mPEG-Zein Micelles
The morphology of the prepared micelles (0.4 mg/mL in distilled water) was assessed
by transmission electron microscopy (TEM), using a JEOL JEM-1200EX® transmission
electron microscope (Jeol, Tokyo, Japan) operating at an accelerating voltage of 80 kV.
Samples (3 µL) were pipetted onto a carbon-coated copper grid (400 mesh size) and were
allowed to air dry overnight before imaging.
2.4.4. Size and Zeta Potential Measurements
The size, polydispersity index (PDI), and zeta potential of Nile red-loaded mPEG-zein
micelles were measured by dynamic light scattering (DLS), using a Malvern Zetasizer
Nano-ZS® at 37 ◦ C (Malvern Instruments Ltd., Malvern, UK). All samples were freshly
prepared and diluted to the concentration of 0.2 mg/mL in 5% (w/v) glucose solution
(refractive index: 1.33) before measurement.
2.4.5. Determination of Nile Red Encapsulation Efficiency
Nile red-loaded mPEG-zein micelles (1 mg) were dispersed in 1 mL distilled water
and centrifuged at 5000 g for 14 min at 25◦ C using an IEC Micromax® centrifuge (Thermo
Scientific, Loughborough, UK). The supernatant was then discarded, and the pellet was
lysed with 1 mL methanol. An aliquot was further diluted with methanol to the desired
concentration range to measure the encapsulated Nile red, which was quantified by spectrofluorometry (λexc : 550 nm, λem : 636 nm, slit widths: 5 nm). The encapsulation efficiency
(EE) was calculated as follows:
EE (%) =

Amount of Nile red loaded in micelles
× 100
Amount of Nile red added in the formulation

2.5. Cellular Uptake
2.5.1. Cell Culture
B16-F10-luc-G5 cell line was cultured in RPMI 1640 medium supplemented with 10%
(v/v) FBS, 1% (v/v) L-glutamine, and 0.5% (v/v) penicillin-streptomycin. Cultures were
maintained at 37 ◦ C in a 5% CO2 atmosphere, and the cells were sub-cultured routinely.
Bone marrow-derived macrophages and dendritic cells were derived from tibia and femur
of 6- to 8-week-old mice as described in the literature [27].
2.5.2. Qualitative Analysis
The cellular uptake of Nile red-loaded mPEG-zein micelles was qualitatively investigated using confocal microscopy. B16-F10-luc-G5 cells were seeded on coverslips in
6-well plates (1 × 105 cells/well) and allowed to adhere overnight. On the following day,
the medium was removed and replaced with a fresh medium containing free Nile red or
equivalent amount of Nile red loaded in mPEG-zein micelles (844 ng Nile red per well) at
37 ◦ C for 2 h. Imaging of the cellular uptake was conducted using a Leica SP5® confocal
microscope (Leica, Wetzlar, Germany). Nile red was excited with the 543 nm laser line and
detected at 615–660 nm. Cell nuclei were stained with Vectashield® mounting medium
containing DAPI, which was excited with the 405 nm laser line and detected at 415–491 nm.
2.5.3. Quantitative Analysis
B16-F10-luc-G5 cells were seeded into 6-well plates at a density of 2 × 105 cells/well
and allowed to grow for 24 h. Uptake was studied by incubating cells with Nile red encapsulated in mPEG-zein micelles or free in solution, as described for confocal microscopy.
After a 2 h incubation, adherent cells were washed and detached (using 250 µL TrypLE®
Express and 500 µL medium per well), followed by analysis on a FACSCanto® flow cytometer using FACSDiva® software (BD, Franklin Lakes, NJ, USA). At least 10,000 cells
were analyzed for each sample.
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2.5.4. Mechanisms of Cellular Uptake
To investigate the endocytosis-mediated uptake, B16-F10-luc-G5 cells were seeded
using the same protocol as in Section 2.5.3. After 24 h, the medium was removed, and the
cells were pretreated with the endocytosis inhibitors chlorpromazine (20 µg/mL), filipin
(5 µg/mL), and colchicine (40 µg/mL) at 37◦ C for 30 min. Afterward, the treatments
were removed and replaced with co-incubation of Nile red-encapsulated mPEG-zein micelles (844 ng Nile red per well) with the inhibitors (chlorpromazine (5 µg/mL), filipin
(3 µg/mL), and colchicine (40 µg/mL)) for another 2 h. The cells were then processed for
flow cytometry analysis as described above.
2.6. Size and Zeta Potential of mPEG-Zein Micelles in the Presence of Human Plasma (HP)
The size and zeta potential of empty mPEG5K-zein and mPEG10K-zein micelles
(1 mg/mL) in cell culture medium with 10% (v/v) HP (sfRPMI + HP) or without HP
(sfRPMI) were measured at 37 ◦ C with a Malvern Zetasizer Nano-ZS® (Malvern Instruments Ltd., Malvern, UK). Samples were vortexed at the start of the experiment and were
further incubated at 37 ◦ C for subsequent measurements at the indicated times without
being vortexed.
2.7. Effect of HP on the Cellular Uptake of mPEG-Zein Micelles
The effect of HP on mPEG-zein micelle uptake by cancer cells, macrophages, and
dendritic cells was examined by flow cytometry. All three cell types were seeded into 6-well
plates at a density of 2 × 105 cells/well and allowed to settle for 24 h. The grown cells
were then incubated in sfRPMI for 1 h, before treatment. Nile red-loaded mPEG5K-zein
and mPEG10K-zein micelles (20 mg/mL in water) were pre-incubated in HP or glucose
solution (5%, w/v) at a volume ratio of 1:1 at 37 ◦ C for 1 h and were added to the cells at
a concentration of 844 ng Nile red per well in serum-free medium. After 2 h treatment,
cancer cells were processed for flow cytometry analysis as described in Section 2.5.3. For
macrophages and dendritic cells, single cell suspensions were obtained by scraping after
the addition of 500 µL medium per well.
2.8. Evaluation of Cell Viability
B16-F10-luc-G5 cancer cells, macrophages, and dendritic cells were seeded into 96well plates at a density of 1.5 × 104 cells/well for 24 h. Next, the cells were incubated
for either 2 h (for macrophages and dendritic cells) or 4 h (for cancer cells) with Nile
red loaded in mPEG-zein micelles or free as a solution (56 ng Nile red per well), using
untreated cells as controls. Following treatment, 50 µL of 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyl-tetrazolium bromide (MTT) solution (5 mg/mL in PBS) was added into each well,
and the cells were incubated for an additional 4 h. The MTT reagent was removed, and
the formazan crystals were dissolved in 200 µL dimethyl sulfoxide. The absorbance was
measured at 570 nm using a Multiskan Ascent® plate reader (Thermo Scientific, Waltham,
MA, USA). Cell viability was calculated as the percentage of relative change of absorbance
compared with the control (untreated cells).
2.9. Preparation of Hard Corona Samples
HP stock solution (0.5 mL) was diluted with 2.5 mL ultrapure water. mPEG5K-zein
and mPEG10K-zein micelles (3 mg) were incubated with the diluted HP (3 mL) at 37 ◦ C for
1 h, followed by 2-step centrifugation (4696× g, 4 ◦ C, 10 min) using a Heraeus Megafuge®
16R centrifuge (Thermo Scientific, Loughborough, UK) to obtain hard corona pellets. The
pellet was resuspended with 100 µL ultrapure water and kept at −20 ◦ C for further study.
2.10. Analysis of Protein Corona
2.10.1. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
The protein samples were diluted with Laemmli sample buffer containing 2-mercaptoethanol (5%, v/v) as a reducing agent at the volume ratio of 1:1. The samples (5 µg protein)
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were reduced at 90 ◦ C for 5 min and loaded onto a 4–20% Mini-PROTEAN® TGXTM gel
(Bio-Rad, Watford, UK). The gel was run with Tris/glycine/SDS buffer at 120 V for 1 h
with Precision Plus ProteinTM Dual Color Standards (Bio-Rad, Watford, UK) as a molecular
standard. The gel was stained with a Silver Stain PlusTM Kit (Bio-Rad, Watford, UK), as
described in the kit’s instruction manual.
2.10.2. Liquid Chromatography–Mass Spectrometry (LC–MS) Analysis
The protein samples were processed by filter-aided sample preparation (FASP) to remove PEG before protein digestion by trypsin (enzyme to protein ratio of 1:100). Trypsinized
peptide samples were analyzed using nanoscale liquid chromatography coupled to electrospray ionization tandem mass spectrometry (nLC-ESI–MS/MS). Online detection of
peptide ion was by electrospray ionization mass spectrometry using an Orbitrap EliteTM
MS (Thermo Scientific, Loughborough, UK). Peptides were separated on a PepmapTM C18
reversed phase column (3 µm, 100 Å, 75 µm × 50 cm) (Thermo Scientific, Loughborough,
UK). Samples were processed with mobile phase A consisting of 0.1% (v/v) formic acid
in water and mobile phase B consisting of acetonitrile (80%, v/v) and water (20%, v/v).
The peptide separation was performed at a fixed solvent flow rate of 0.3 µL/min, using
a gradient of 4–100% mobile phase B over 120 min. The Orbitrap EliteTM MS acquired
full-scan spectra in the mass range of m/z 300–2000 Da for a high-resolution precursor
scan at a set mass resolving power of 60,000 (at 400 m/z). Collision-induced dissociation
was performed in the linear ion trap with the 20 most abundant precursors using rapid
scan mode.
2.10.3. Protein Identification
Data were analyzed using the Mascot search engine (v2.6.2, Matrix Science, London,
UK) against the NCBIprot database using the Homo sapiens taxonomy. A mass tolerance of
10 ppm for the precursor and 0.3 Da MS/MS was used for peptide matching.
2.11. Statistical Analysis
All data were reported as means ± standard error of the mean (SEM). Statistical
analysis was performed by one-way analysis of variance (ANOVA) followed by Tukey
multiple comparison post-test (Minitab® software, State College, PE, USA) at a significance
level of 0.05.
3. Results and Discussion
3.1. Synthesis and Characterization of PEGylated Zein
mPEG-Zein was successfully synthesized by the formation of an amide bond between
the terminal amino group in yellow zein and mPEG-succinimidyl carboxymethyl (mPEGSCM) (MW 5 and 10 kDa) (Scheme 1, Table 1). mPEG-SCM is a high-quality amine-reactive
PEG product with a stable non-degradable linker between the PEG polymeric chain and
the N-hydroxysuccinimide (NHS) ester. Zein contains 22% of asparagin and glutamine [9]
that could theoretically be used for PEGylation due to the presence of an amino group
in the side chain of these amino acids. However, these amino acids have been found to
be inaccessible for conjugation [28], unlike the glutamine at the N-terminal of zein [9].
The PEGylation of zein was confirmed by ATR–FTIR analysis (Figure S1). Primary amide
peaks of zein were observed at 1643 and 1516 cm−1 on the FTIR spectra of mPEG-zein.
The stretching vibration of the carbonyl in the CH2 CH2 O groups of PEG at 840–960 cm−1
and the methyl group at 2742 cm−1 appeared in both the spectra of mPEG5K-zein and
mPEG10K-zein. Furthermore, the NHS ester peak of mPEG at 1741 cm−1 disappeared
after conjugation, unlike the spectra resulting from the unconjugated mixture of zein and
PEG [19,20]. These demonstrated that the PEGylation of zein was successful.
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mPEG5K‐zein and mPEG10K‐zein. Furthermore, the NHS ester peak of mPEG at 1741
cm−1 disappeared after conjugation, unlike the spectra resulting from the unconjugated
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The assembly behavior of mPEG-zein was further studied by a steady-state fluorescence technique using Nile red as a hydrophobic fluorescent probe. Nile red is weakly
fluorescent in water. However, its fluorescence intensity increased with increasing mPEGzein concentrations, as Nile red was solubilized within the hydrophobic core of the micelles [29]. The CMC values decreased by reducing the MW of conjugated PEG (81.7 µg/mL
for PEG5K versus 88.3 µg/mL for PEG10K) (Figure 2A,C). This could be explained by
the overall higher hydrophobic content of the smaller PEG conjugate over the larger PEG
conjugate, as the micelle formation occurs mainly through the hydrophobic interactions
among zein molecules. The CMC value obtained for mPEG5K-zein micelles was relatively
higher than that previously published (55 µg/mL and 20 µg/mL in Podaralla et al. [19] and
Song et al. [20], respectively), when using pyrene as a fluorescence probe. This difference
might be due to the different hydrophobic probes used, as well as the type of zein used
as starting material. Podaralla et al. used white zein, and Song et al. used purified α-zein,
while yellow zein was chosen in our study [19,20]. Chan et al. previously demonstrated
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that the CMC value for diblock copolymer micelles characterized using pyrene was lower
Pharmaceutics 2022, 14, x FOR PEER REVIEW
8 of 20
than that using Nile red (15.1 mg/mL by pyrene versus 19.5 mg/mL by Nile red) [30].

Nevertheless, the CMC values obtained in our study were low, indicating high stability of
the mPEG-zein micelles.
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the type of zein used as starting material. Podaralla et al. used white zein, and Song et al.
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independent of the PEG MW [33,34]. It was even found to decrease with increasing PEG
MW, for example, in the case of cholesterol-bearing PEGylated polymeric micelles, due to
the overall low cholesterol content in the co-polymer chain for polymers with higher MW
PEG, making these micelles less favorable for drug encapsulation [35].
3.3. Cellular Uptake of mPEG-Zein Micelles
The uptake of mPEG-zein micelles by B16-F10-luc-G5 melanoma cancer cells was
evaluated using confocal microscopy (Figure 3A). Both mPEG-zein
11 micelles
of 20
could deliver Nile red into the cells following 2 h incubation. Fluorescent Nile red, predominantly located in the cytoplasm, was also found to be co-localized in the nuclei following
treatment with mPEG5K-zein micelles, unlike mPEG10K-zein, which showed weak red
involved macropinocytosis instead of caveolin‐mediated or clathrin‐mediated pathways
fluorescence signals within the nucleus. Higher Nile red accumulation in the cells was
[16,41].
observed from Nile red solution over the micelles.
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3.4. Size and Zeta Potential of mPEG‐Zein Micelles in the Presence of Proteins
mPEG5K‐zein and mPEG10K‐zein micelles were incubated in cell culture medium in
the presence of proteins, and their size were measured at various times by DLS. The
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The cellular uptake of mPEG-zein micelles was further confirmed by flow cytometry
(Figure 3B and Figure S2). The mean fluorescence intensity (MFI) of cells incubated with
Nile red solution (12,796 ± 712 arbitrary units (a.u.)) was at least three-fold higher than
that of mPEG-zein micelles, which correlated well with the observation from confocal
microscopy. This could be explained by the different cellular uptake mechanisms used
by Nile red solution and the micelles: passive diffusion of the Nile red solution to the
cells, while the micelles are taken up by endocytosis. Furthermore, mPEG5K-zein micelles
were more efficacious in delivering Nile red into the cells, by approximately two-fold in
comparison with its longer chain counterparts (MFI of 4256 ± 195 a.u. for mPEG5K-zein
versus MFI of 2169 ± 85 a.u. for mPEG10K-zein), therefore demonstrating that PEGylation
with a shorter PEG chain length could improve the cellular uptake efficacy of the zein
micelles. Higher uptake with a shorter PEG chain length was consistent with several
types of PEGylated nanocarriers [34,36,37]. Increasing PEG MW was shown to prevent
nanoparticle-cell interactions, as higher MW PEG grafting led to a larger surface shielding
of the micelles [38,39]. Hence, a relatively lower uptake of the mPEG10K formulation
compared to the mPEG5K-based one in cancer cells could be explained by a decrease in
cell adhesion.
To investigate the endocytosis pathways of mPEG-zein micelles entering B16-F10-lucG5 cells, various pathway-specific inhibitors were used: chlorpromazine as the inhibitor of
clathrin-mediated endocytosis, filipin as the inhibitor of caveolae-mediated endocytosis,
and colchicine as the inhibitor of macropinocytosis [40]. The uptake of both mPEG-zein
micelles was inhibited by chlorpromazine by about 20% (Figure 3C), indicating that these
micelles were mainly internalized by clathrin-mediated endocytosis, which is the main
route by which nanocarriers enter the cells [40]. Filipin and colchicine did not decrease the
cellular uptake of the micelles, suggesting that caveolae-mediated and macropinocytosismediated endocytosis did not participate in the uptake of the micelles. The cellular uptake
of other zein-based delivery systems via energy-dependent endocytosis was also previously reported, however involving different endocytosis pathways. Doxorubicin-loaded
zein nanoparticles and caseinate-zein nanoparticles involved macropinocytosis instead of
caveolin-mediated or clathrin-mediated pathways [16,41].
3.4. Size and Zeta Potential of mPEG-Zein Micelles in the Presence of Proteins
mPEG5K-zein and mPEG10K-zein micelles were incubated in cell culture medium in
the presence of proteins, and their size were measured at various times by DLS. The micelle
size slightly increased in the presence of FBS (Figure S3), probably due to the formation of
the protein corona on the surface of the micelles, as previously reported [42–45]. However,
the magnitude of the size change can vary depending on the delivery systems. For example,
the average size of black phosphorus nanosheets-corona complexes increased by 8% (from
338.4 ± 2.3 nm to 365.3 ± 5.9 nm), while the diameter of black phosphorus quantum dots
unexpectedly increased over 6000% (from 5.6 ± 1.4 nm to 362.5 ± 5.6 nm) after the protein
corona was formed [45].
When the micelles were allowed to interact with HP, such an increase in size was
not observed (Figure 4). The size of mPEG5K-zein micelles stayed the same over 24 h,
independent of the presence or absence of HP (from 135.4 ± 1.4 nm to 130.9 ± 4.5 nm after
24 h). Likewise, mPEG10K-zein micelles displayed a similar size over 24 h. The presence
of HP led to a slight decrease of the micelle size (212.1 ± 0.9 nm and 225.9 ± 6.0 nm,
respectively with and without HP after 24-h incubation). In general, proteins interact
with nanoparticles by forming a corona around their surface, resulting in a thickening of
the nanoparticle surface and a subsequent increase in their size [42–45]. However, they
may lead to a size reduction due to osmotically driven shrinkage [46]. For our delivery
systems, the latter effect may be predominant, particularly for the mPEG10K formulation.
Repulsive forces of mPEG10K-zein micelles against HP could prevent the formation of a
dense protein corona. Instead, proteins that are impermeable to the micelles might induce
osmotic pressure, which caused water to escape from the micelle and the micelle to shrink.
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Figure 4. Size of mPEG5K-zein and mPEG10K-zein micelles in the presence or absence of hu-

Figure
Size of
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man4.plasma
(HP)
(“sfRPMI”: serum-free
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(v/v)
HP)
(n
=
3).
plasma (HP) (“sfRPMI”: serum‐free RPMI medium, “sfRPMI + HP”: serum‐free RPMI
10% (v/v)Although
HP) (n =these
3). micelles did not exhibit an increase in their size following incubation
with HP, a drop in zeta potential values by about 8 mV was observed (from 28.6 ± 1.0 mV
to 20.3 ± 2.7 mV for mPEG5K-zein and from 30.9 ± 0.4 mV to 23.0 ± 0.8 mV for mPEG10Kzein). This might be due to the binding of negatively charged proteins on the micelle
surface. The neutralization of the particle surface charge resulting from the binding of
proteins with opposite charges on the nanoparticle surface was in accordance with data
published by several groups for other delivery systems [37,45,47].
Surface modification of delivery systems with PEG has been reported to prevent
nonspecific interactions with proteins as hydrophilic PEG chains become compressed
when proteins approach the surface, thus creating a thermodynamic barrier to protein
adsorption [25,48–50]. The presence of FBS or HP in the medium surrounding the micelles
led to minimal changes in the hydrodynamic radius, indicating limited micelle–protein
interactions. Our results suggest that both mPEG5K-zein and mPEG10K-zein micelles
exhibited stealth properties regardless of the PEG chain length.
3.5. Effect of Protein Corona on the Cellular Uptake of mPEG-Zein Micelles
To investigate the impact of protein corona on drug delivery vehicles in contact with
biological fluids, HP was used to prepare pre-formed corona micelles. In this study, Nile
red-loaded mPEG5K-zein and mPEG10K-zein micelles were pre-incubated in HP or in a
glucose solution (5%, w/v) at 37 ◦ C for 1 h to allow protein adsorption on the surface of the
micelles. They were then added to B16-F10-luc-G5 cells in a serum-free medium for 2 h
to determine the effect of a preformed corona on cellular uptake levels. Flow cytometry
analysis revealed that pre-coating the micelles with HP had no substantial effect on the
uptake of Nile red by the cancer cells, independent of the PEG chain length used in the
formulations (Figure 5).

liposome–HP complexes increased with respect to their counterparts in the absence
corona [37].
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Figure 5. Cellular uptake of Nile red loaded in mPEG5K-zein (“5K”) and mPEG10K-zein (“10K”)
precoated with HP (gray) or glucose 5% (w/v) solution as control (light gray), by B16-F10Figuremicelles
5. Cellular
uptake of Nile red loaded in mPEG5K‐zein (“5K”) and mPEG10K‐zein (“
luc-G5 cancer cells, macrophages, and dendritic cells (n = 6) (*: p < 0.05, compared with controls
micelles precoated with HP (gray) or glucose 5% (w/v) solution as control (light gray), by B1
without protein corona).

luc‐G5 cancer cells, macrophages, and dendritic cells (n = 6) (*: p < 0.05, compared with co
However,
following intravenous administration, nanomaterials are often covered by
without protein
corona).

corona proteins. Some of them can act as opsonins to influence the recognition and clearance
of the particles by cells of the mononuclear phagocyte system (MPS), predominantly
The
viability of B16‐F10‐luc‐G5 cancer cells, macrophages, and dendritic cell
dendritic cells in the bloodstream and macrophages at tissues, and thus potentially prevent
assessed
following
treatment
with
Nile
red‐loaded
micelles
a
the particles
from reaching
their target
tumors
[45,48].
Therefore, themPEG‐zein
cellular uptake of
the
preformed conditions
corona mPEG-zein
murineuptake
bone marrow-derived
macrophages
and
experimental
usedmicelles
in the by
cellular
experiments
(same concentratio
dendritic
cells
was
also
evaluated.
As
shown
in
Figure
5,
precoating
the
micelles
with
HP cells
treatment for 4 h for the cancer cells and 2 h for the macrophages and dendritic
resulted in a decreased uptake by macrophages (9% uptake reduction for mPEG5K-zein
viability
of the
three
cell types
higher
than 80%The
following
with
and 18%
uptake
reduction
for itswas
mPEG10K
counterpart).
uptake of treatment
mPEG5K-zein
and both m
formulations,
suggesting
that
the micelles
not toxic
to and
the 19%,
cellsrespectively
at these experim
mPEG10K-zein
micelles by
dendritic
cells was were
also reduced
by 22%
after
pre-incubation
with
HP.
The
adsorption
of
HP
on
the
micelle
surface,
therefore,
had treated
conditions. It was not significantly different from that observed with cells
a positive impact on the uptake of the formulations by macrophages and dendritic cells.
Nile red
solution or untreated cells (Figure S5). This confirmed that the differences
The effect of FBS on the cellular uptake of mPEG-zein micelles was also studied. We found
cellular
analysis
associated
withof the
toxicitybyof
micelles.
thatuptake
the presence
of FBS were
slightlynot
decreased
the uptake
the micelles
allthe
three
cell types
(Figure S4). The small effect of the protein corona on the cellular uptake of our mPEG-zein
micelles could
explained
by a decreased protein binding resulting from the stealth
3.6. Analysis
of thebe
Protein
Corona
properties of PEG [51].
The The
harddecrease
coronainproteins
were
obtained
after 1micelles
h incubation
mPEG‐zein
mi
the cellular
uptake
of pretreated
(human of
plasma)
by
macrophages
and
dendritic
cells
could
be
explained
by
the
lowered
micelle–cell
memin HP, followed by two‐step centrifugation. They were then separated using SDS‐P
brane adhesion
the adsorption
of proteins
around the
micelle
surface.
The small
and visualized
bycaused
silverbystaining
to gain
an overview
about
their
protein
signature
decrease in cellular uptake is probably due to the decreased protein binding resulting from
protein
patterns of mPEG5K‐zein and mPEG10K‐zein micelles were almost ide
the stealth properties of PEG. Furthermore, PEGylation could not inhibit serum protein
(Figure
S6). Both
micelles
were
mainly
covered
(band at
~62 kDa),
adsorption
completely,
even
at high
grafting
density, by
butalbumin
it could selectively
suppress
the the p
adsorption
of
specific
proteins,
such
as
opsonins
[48].
Taken
together,
these
two
factors
with the highest concentration in blood [44,55]. However, it is well accepted
might be the reason for a decreased uptake by macrophages and dendritic cells. This
numerous
proteins that exhibit a low abundance in blood are also highly enriched o
stealth effect is not specific to mPEG, as Schöttler et al. [52] also observed a decrease in
particle
surface
[50,52].
waswas
applied
fortothe
identificatio
protein
adsorption
andTherefore,
the presencenLC‐ESI–MS/MS
of a specific protein that
necessary
prevent
a
the relative
quantification
the hard
corona composition,
allowed for
nonspecific
cellular uptake ofof
polystyrene
nanocarriers
after modificationwhich
with poly(ethyl
ethylene
phosphate)
detailed
insights
about(PEEP).
the protein adsorption behavior.

A total of 132 and 109 proteins were identified from the protein coronas reco
from mPEG5K‐zein and mPEG10K‐zein samples, respectively. Of these protein
proteins appeared on both types of micelles. All identified proteins of varying
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The relationship between the protein corona and nanoparticle uptake efficiency has
previously been investigated in several nanomaterials. Lesniak et al., for instance, demonstrated a significant inhibition of the uptake of silica nanoparticles in the presence of serum
by human lung cancer A549 cells (1,500,000 a.u. in serum-free versus 10,500 a.u. in complete medium, after 2 h incubation) [43]. As nanoparticle uptake involves cell membrane
adsorption followed by subsequent internalization via energy-dependent endocytosis [53],
the lowered particle–cell membrane adhesion due to the adsorption of serum proteins on
the nanoparticle surface thereby caused a reduction in internalization efficiency [54]. Nevertheless, a protein corona could affect nanoparticle uptake efficiency with different outcomes.
Yan et al. reported that the adsorption of FBS on disulfide-stabilized poly-(methacrylic acid)
nanoporous polymer particles significantly decreased the cellular uptake in monocytes
by at least 50%. In contrast, it did not affect the uptake level in macrophages [44]. Pozzi
et al. also demonstrated that the cell internalization of PEGylated multicomponent cationic
liposomes in PC3 prostate cancer cells decreased from 80% to 50% after incubation with HP,
but the cellular uptake of non-PEGylated liposome–HP complexes increased with respect
to their counterparts in the absence of the corona [37].
The viability of B16-F10-luc-G5 cancer cells, macrophages, and dendritic cells was
assessed following treatment with Nile red-loaded mPEG-zein micelles at the experimental
conditions used in the cellular uptake experiments (same concentration and treatment for
4 h for the cancer cells and 2 h for the macrophages and dendritic cells). The viability of the
three cell types was higher than 80% following treatment with both micelle formulations,
suggesting that the micelles were not toxic to the cells at these experimental conditions. It
was not significantly different from that observed with cells treated with Nile red solution
or untreated cells (Figure S5). This confirmed that the differences in the cellular uptake
analysis were not associated with the toxicity of the micelles.
3.6. Analysis of the Protein Corona
The hard corona proteins were obtained after 1 h incubation of mPEG-zein micelles in
HP, followed by two-step centrifugation. They were then separated using SDS-PAGE and
visualized by silver staining to gain an overview about their protein signatures. The protein
patterns of mPEG5K-zein and mPEG10K-zein micelles were almost identical (Figure S6).
Both micelles were mainly covered by albumin (band at ~62 kDa), the protein with the
highest concentration in blood [44,55]. However, it is well accepted that numerous proteins
that exhibit a low abundance in blood are also highly enriched on the particle surface [50,52].
Therefore, nLC-ESI–MS/MS was applied for the identification and the relative quantification of the hard corona composition, which allowed for more detailed insights about the
protein adsorption behavior.
A total of 132 and 109 proteins were identified from the protein coronas recovered from
mPEG5K-zein and mPEG10K-zein samples, respectively. Of these proteins, 48 proteins
appeared on both types of micelles. All identified proteins of varying MW, molecular weight
search (MOWSE) score, and exponentially modified protein abundance index (emPAI) are
presented in Table S1. Grouping the proteins according to their MW showed that low MW
proteins (<25 kDa) were predominantly found on mPEG5K-zein micelles, while proteins
with medium size (25–100 kDa) were significantly enriched on mPEG10K-zein micelles
(Figure 6B). We also detected a very low level of high MW proteins (>100 kDa) on the
surface of both micelles. This result indicates a distinct protein binding pattern on each
micelle type.
The bound proteins were further classified according to their functions (Figure 6A).
Both micelle types were mainly covered by immunoglobulins, lipoproteins, the proteins involved in tissue leakage, and other plasma components. We found a significant enrichment
of immunoglobulins (49%) on the surface of mPEG5K-zein micelles. The most abundant
protein from the corona recovered from mPEG5K-zein micelles was the immunoglobulin
light chain (13%), followed by albumin (10%). In contrast, proteins that preferentially
bound to mPEG10K-zein micelles were other plasma components (33%). Lipoproteins and
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Our results suggest that plasma protein adsorption was influenced by PEG MW, since
4. Conclusions
different protein compositions and contents were detected from the corona of both micelle
In this work, we demonstrated that yellow zein could be successfully conjugated
types. These results were supported by several publications. Gref et al. revealed that the
with PEG and was able to assemble into micelles, entrapping a model hydrophobic
type and amount of the corona proteins were determined by the PEG chain length and
substance, Nile red. mPEG‐zein micelles could deliver Nile red into the B16‐F10‐luc‐G5
density at the particle surface as well as the nature of the core material [25]. In a recent study,
melanoma cell line via clathrin‐mediated endocytosis, with a higher cellular uptake
Partikel et al. observed a significant depletion of bound proteins, opsonins, in terms of the
observed when using smaller chain length PEG5K. The present study provides the first
amount and number, due to PEGylation on PLGA nanoparticles [50]. The adsorption of
investigation of the impact of the protein corona on mPEG‐zein micelle uptake by cancer
opsonins, such as immunoglobulins and complement factors, onto the nanoparticle surface
cells and immune cells. Overall, PEGylation of zein could confer stealth effects on the
is thought to promote phagocytosis and clearance of the particles by cells of the MPS. By
micelle surface, regardless of the PEG chain length, thereby minimizing the adsorption of
proteins on the micelles. Most importantly, it was shown for the first time that the
presence of HP did not have any impact on the uptake of mPEG‐zein micelles by the
melanoma cancer cells, independent of the MW PEG used in the formulations. In addition,
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contrast, the binding of dysopsonins, such as albumin, has been shown to prolong blood
circulation lifetime. Ogawara et al. reported that pre-coating polystyrene nanoparticles with
albumin could suppress the association of serum proteins with opsonic activity, resulting
in prolonged blood circulation after intravenous injection in rats [56]. Instead of albumin,
Schöttler et al. identified clusterin (also known as apolipoprotein J) as another protein with
dysopsonic properties [52]. Clusterin was also detected in our hard corona proteins, but at
very low levels (<1% in both micelle systems). However, we found albumin and various
apolipoproteins, mainly apolipoproteins A-I and E, to be prominent in the protein corona
recovered from both micelles. Apolipoproteins generally exhibit dysopsonic function, as
reported previously [50,52]. In summary, even though immune relevant proteins, such as
immunoglobulins, were present in high percentages in the hard corona recovered from our
micelles, in particular in the case of PEG5K, we also found an enrichment of dysopsonins,
such as albumin and apolipoproteins. The presence of dysopsonins might antagonize the
biological effects of micelle-bound opsonins [55], leading to a limited decrease in cellular
uptake by macrophages and dendritic cells.
4. Conclusions
In this work, we demonstrated that yellow zein could be successfully conjugated with
PEG and was able to assemble into micelles, entrapping a model hydrophobic substance,
Nile red. mPEG-zein micelles could deliver Nile red into the B16-F10-luc-G5 melanoma
cell line via clathrin-mediated endocytosis, with a higher cellular uptake observed when
using smaller chain length PEG5K. The present study provides the first investigation of the
impact of the protein corona on mPEG-zein micelle uptake by cancer cells and immune cells.
Overall, PEGylation of zein could confer stealth effects on the micelle surface, regardless of
the PEG chain length, thereby minimizing the adsorption of proteins on the micelles. Most
importantly, it was shown for the first time that the presence of HP did not have any impact
on the uptake of mPEG-zein micelles by the melanoma cancer cells, independent of the
MW PEG used in the formulations. In addition, it decreased the uptake of the micelles by
macrophages and by dendritic cells for both micelle formulations. This effect might be due
to the presence of dysopsonins, such as albumin and apolipoproteins, in the hard corona
surrounding the micelles that might antagonize the biological effects of the micelle-bound
opsonins. These results, therefore, make PEGylated zein micelles promising candidates to
further investigate as drug delivery vehicles for cancer therapy.
Supplementary Materials: The following supporting information can be downloaded at: https:
//www.mdpi.com/article/10.3390/pharmaceutics14020439/s1, Figure S1. FTIR spectra of zein
(A), mPEG5K (B), mPEG10K (C), mPEG5K-zein conjugate (D), mPEG10K-zein conjugate (E), nonconjugated mixture of mPEG5K with zein (F), and non-conjugated mixture of mPEG10K with zein (G);
Figure S2. Flow cytometry histograms of B16-F10-luc-G5 cells following 2 h incubation with Nile red
loaded in mPEG5K-zein (A) and mPEG10K-zein (B) micelles, Nile red solution (C), or left untreated
(D); Figure S3. Size of mPEG5K-zein and mPEG10K-zein micelles in the presence or absence of 10%
(v/v) FBS, over 24 h (“cDMEM”: complete DMEM medium, “sfDMEM”: serum-free DMEM medium)
(n = 3); Figure S4. Effect of FBS on the cellular uptake of mPEG-zein micelles. Nile red-loaded
mPEG5K-zein and mPEG10K-zein micelles were pre-incubated in complete medium or in serum-free
medium at 37◦ C for 1 h to allow protein adsorption to the surface of the micelles. (A) Time-dependent
uptake of the pre-formed corona micelles in complete and serum-free medium by B16-F10-luc-G5 cells
(cRPMI: complete RPMI medium, sfRPMI: serum-free RPMI medium) (n = 3). (B) Cellular uptake of
the pre-formed corona micelles in cRPMI (dark gray) or sfRPMI (light gray) by macrophages and
dendritic cells (n = 6) (*: p < 0.05, compared with sfRPMI); Figure S5. Viability of B16-F10-luc-G5
cancer cells (A), macrophages (B), and dendritic cells (C) treated with Nile red-loaded mPEG-zein
micelles for 4 h (n = 15) (cancer cells) or 2 h (n = 10) (macrophages and dendritic cells) (controls:
cells treated with Nile red solution or left untreated). There was no statistical difference between the
treatments; Figure S6. SDS-PAGE gels of protein corona surrounding mPEG-zein micelles following
incubation in cDMEM, sfDMEM (A) and HP (B) at 37 ◦ C for 1 h. The analysis was performed in
duplicate—for clarity only one replicate is shown. Protein bands at ~22–24 kDa correspond to α-zein.
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Other zein fractions were also detected from micelles that were incubated with sfDMEM. However,
the intensities of these bands were considerably low; Table S1. List of hard corona proteins on
mPEG5K-zein and mPEG10K-zein micelles after exposure to human plasma at 37 ◦ C for 1 h (n.d.:
not detected).
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